IL1B and cryopyrin-associated periodic syndrome: The mutations we compiled from the literature lead to a broad range of clinical phenotypes and varying degrees of dysregulation of inflammasome activity, including increased IL-1β cytokine production and decreased monocyte sensitivity to inflammasome-activating triggers such as lipopolysaccharides as observed in CAPS patients (64).